MetLife Investment Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,462
| Closed | -$16.2K | – | 2790 |
|
|
2021
Q4 | $16.2K | Sell |
6,462
-26,366
| -80% | -$65.9K | ﹤0.01% | 2488 |
|
|
2021
Q3 | $168K | Buy |
32,828
+9,327
| +40% | +$47.8K | ﹤0.01% | 2194 |
|
|
2021
Q2 | $195K | Sell |
23,501
-12,347
| -34% | -$103K | ﹤0.01% | 2188 |
|
|
2021
Q1 | $312K | Buy |
35,848
+4,350
| +14% | +$37.9K | ﹤0.01% | 1792 |
|
|
2020
Q4 | $342K | Sell |
31,498
-8,472
| -21% | -$92K | ﹤0.01% | 1684 |
|
|
2020
Q3 | $477K | Sell |
39,970
-9,258
| -19% | -$110K | 0.01% | 1390 |
|
|
2020
Q2 | $791K | Buy |
49,228
+16,843
| +52% | +$270K | 0.01% | 1124 |
|
|
2020
Q1 | $502K | Sell |
32,385
-3,837
| -11% | -$59.5K | 0.01% | 1214 |
|
|
2019
Q4 | $891K | Hold |
36,222
| – | – | 0.01% | 1150 |
|
|
2019
Q3 | $374K | Sell |
36,222
-10,574
| -23% | -$109K | ﹤0.01% | 1571 |
|
|
2019
Q2 | $587K | Buy |
46,796
+21,721
| +87% | +$273K | 0.01% | 1382 |
|
|
2019
Q1 | $311K | Hold |
25,075
| – | – | ﹤0.01% | 1733 |
|
|
2018
Q4 | $154K | Hold |
25,075
| – | – | ﹤0.01% | 2056 |
|
|
2018
Q3 | $266K | Hold |
25,075
| – | – | ﹤0.01% | 1928 |
|
|
2018
Q2 | $340K | Buy |
25,075
+4,155
| +20% | +$56.3K | ﹤0.01% | 1645 |
|
|
2018
Q1 | $371K | Hold |
20,920
| – | – | ﹤0.01% | 1556 |
|
|
2017
Q4 | $263K | Buy |
+20,920
| New | +$263K | ﹤0.01% | 1774 |
|